314 related articles for article (PubMed ID: 18521524)
1. PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a meta-analysis of 19 studies comprising 3,003 patients.
Crescente M; Di Castelnuovo A; Iacoviello L; de Gaetano G; Cerletti C
Thromb Haemost; 2008 Jun; 99(6):1129-31. PubMed ID: 18521524
[No Abstract] [Full Text] [Related]
2. Aspirin resistance: focus on clinical endpoints.
Pusch G; Feher G; Kotai K; Tibold A; Gasztonyi B; Feher A; Papp E; Lupkovics G; Szapary L
J Cardiovasc Pharmacol; 2008 Dec; 52(6):475-84. PubMed ID: 19034037
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cationic propyl gallate and adenosine diphosphate for the measurement of aspirin effectivity with optical aggregometry.
Motovska Z; Sujanova Z; Wimmerova S; Ardo J; Skrakova M; Widimsky P
Transl Res; 2007 Oct; 150(4):246-52. PubMed ID: 17900512
[TBL] [Abstract][Full Text] [Related]
4. Aspirin resistance in patients with chronic renal failure.
Tanrikulu AM; Ozben B; Koc M; Papila-Topal N; Ozben T; Caymaz O
J Nephrol; 2011; 24(5):636-46. PubMed ID: 21279952
[TBL] [Abstract][Full Text] [Related]
5. Risk stratification after coronary artery bypass surgery by a point-of-care test of platelet function.
Bevilacqua S; Alkodami AA; Volpi E; Cerillo AG; Berti S; Glauber M; Gianetti J
Ann Thorac Surg; 2009 Feb; 87(2):496-502. PubMed ID: 19161767
[TBL] [Abstract][Full Text] [Related]
6. Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapy.
Christie DJ; Kottke-Marchant K; Gorman RT
Platelets; 2008 Mar; 19(2):104-10. PubMed ID: 17852773
[TBL] [Abstract][Full Text] [Related]
7. Aspirin non-responder status in patients with recurrent cerebral ischemic attacks.
Grundmann K; Jaschonek K; Kleine B; Dichgans J; Topka H
J Neurol; 2003 Jan; 250(1):63-6. PubMed ID: 12527994
[TBL] [Abstract][Full Text] [Related]
8. Using the Platelet Function Analyzer-100 for monitoring aspirin therapy.
Poulsen TS; Mickley H; Korsholm L; Licht PB; Haghfelt T; Jørgensen B
Thromb Res; 2007; 120(2):161-72. PubMed ID: 17052745
[TBL] [Abstract][Full Text] [Related]
9. A critical appraisal of the phenomenon of aspirin resistance.
Svenstrup Poulsen T; Kristensen SR; Atar D; Mickley H
Cardiology; 2005; 104(2):83-91. PubMed ID: 16020925
[TBL] [Abstract][Full Text] [Related]
10. Platelet function testing in cardiovascular diseases.
Michelson AD
Circulation; 2004 Nov; 110(19):e489-93. PubMed ID: 15533872
[No Abstract] [Full Text] [Related]
11. Lack of aspirin-induced decrease in thrombin formation in subjects resistant to aspirin.
Undas A; Placzkiewicz-Jankowska E; Zieliński L; Tracz W
Thromb Haemost; 2007 Jun; 97(6):1056-8. PubMed ID: 17549314
[No Abstract] [Full Text] [Related]
12. Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologists.
Angiolillo DJ; Suryadevara S; Capranzano P; Zenni MZ; Guzman LA; Bass TA
Catheter Cardiovasc Interv; 2009 Jan; 73(1):1-14. PubMed ID: 19089929
[TBL] [Abstract][Full Text] [Related]
13. Aspirin resistance: does it exist and is it an important clinical problem?
Eikelboom J
Clin Adv Hematol Oncol; 2006 Apr; 4(4):268-70. PubMed ID: 16728937
[No Abstract] [Full Text] [Related]
14. [A current problem in atherothrombotic diseases--aspirin resistance: definition, mechanisms, determination with laboratory tests and clinical implications].
Pamukçu B; Oflaz H; Nişanci Y
Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():20-6. PubMed ID: 18160363
[TBL] [Abstract][Full Text] [Related]
15. Optical platelet aggregometry does not appear useful as a means of assessing the risk of recurrent vascular events in aspirin-treated patients.
Sztriha LK; Sas K; Seres E; Boda K; Lenti L; Csifcsak G; Kovacs N; Vecsei L
Acta Neurol Scand; 2008 Apr; 117(4):250-4. PubMed ID: 17961197
[TBL] [Abstract][Full Text] [Related]
16. Aspirin resistance.
Tran HA; Anand SS; Hankey GJ; Eikelboom JW
Thromb Res; 2007; 120(3):337-46. PubMed ID: 17241655
[TBL] [Abstract][Full Text] [Related]
17. Monitoring aspirin treatment in patients with thrombocytosis: comparison of the platelet function analyzer (PFA)-100 with optical aggregometry.
Tsantes AE; Mantzios G; Giannopoulou V; Tsirigotis P; Bonovas S; Rapti E; Mygiaki E; Kartasis Z; Sitaras NM; Dervenoulas J; Travlou A
Thromb Res; 2008; 123(1):100-7. PubMed ID: 18430462
[TBL] [Abstract][Full Text] [Related]
18. Laboratory-defined aspirin resistance and recurrent cardiovascular events.
Fontana P; Reny JL
Arch Intern Med; 2008 Mar; 168(5):549-50. PubMed ID: 18332305
[No Abstract] [Full Text] [Related]
19. Drug insight: aspirin resistance-fact or fashion?
Maree AO; Cox D; Fitzgerald DJ
Nat Clin Pract Cardiovasc Med; 2007 Mar; 4(3):E1; author reply E2. PubMed ID: 17330121
[No Abstract] [Full Text] [Related]
20. Aspirin and clopidogrel resistance-a myth or reality: an update.
Gupta S; Gupta MM
Indian Heart J; 2008; 60(3):245-53. PubMed ID: 19240315
[No Abstract] [Full Text] [Related]
[Next] [New Search]
